TY - JOUR
T1 - Kinetics and mechanism of the comproportionation reaction between oxoammonium cation and hydroxylamine derived from cyclic nitroxides
AU - Israeli, Avner
AU - Patt, Miriam
AU - Oron, Miriam
AU - Samuni, Amram
AU - Kohen, Ron
AU - Goldstein, Sara
N1 - Funding Information:
This research was supported by grant from the Israel Science Foundation of the Israel Academy of Sciences.
PY - 2005/2/1
Y1 - 2005/2/1
N2 - Cyclic nitroxides demonstrate antioxidative activity in numerous in vitro and in vivo models, which frequently involves the participation of the reduced and oxidized forms of the nitroxide, namely, the hydroxylamine and oxoammonium cation. Generally, cellular reducing equivalents facilitate rapid enzymatic as well as nonenzymatic reduction of nitroxides in the tissue. On the other hand, the reaction of nitroxides with various radicals yields the highly oxidizing oxoammonium cation, which mediates the catalytic effect of nitroxides in selective oxidation of alcohols. Hence, nitroxides might act as both anti- and pro-oxidants. Therefore, the comproportionation reaction between the oxoammonium cation and the hydroxylamine might play a role in lowering the pro-oxidative activity of nitroxides. Although the comproportionation reaction has previously been studied, there is no agreement regarding its kinetic features. We investigated the reaction of the reduced forms of 2,2,6,6- tetramethylpiperidinoxyl (TPO) and 4-OH-2,2,6,6-tetramethylpiperidinoxyl (4-OH-TPO) with the oxoammonium cation derived from TPO at various pHs using rapid-mixing stopped-flow and EPR spectrometry. From the pH dependence of the reaction rate constants we determined the pK 1 of the respective hydroxylamines to be 7.5 and 6.9, respectively. The reduction potentials of the hydroxylamines were determined by cyclic voltammetry, and from their dependence on pH, we obtained the same pK 1 values. The rate constant of the comproportionation reaction does not exceed 20 M -1 s -1 in the physiological pH range and, therefore, cannot greatly contribute toward recycling of the nitroxides in the tissue.
AB - Cyclic nitroxides demonstrate antioxidative activity in numerous in vitro and in vivo models, which frequently involves the participation of the reduced and oxidized forms of the nitroxide, namely, the hydroxylamine and oxoammonium cation. Generally, cellular reducing equivalents facilitate rapid enzymatic as well as nonenzymatic reduction of nitroxides in the tissue. On the other hand, the reaction of nitroxides with various radicals yields the highly oxidizing oxoammonium cation, which mediates the catalytic effect of nitroxides in selective oxidation of alcohols. Hence, nitroxides might act as both anti- and pro-oxidants. Therefore, the comproportionation reaction between the oxoammonium cation and the hydroxylamine might play a role in lowering the pro-oxidative activity of nitroxides. Although the comproportionation reaction has previously been studied, there is no agreement regarding its kinetic features. We investigated the reaction of the reduced forms of 2,2,6,6- tetramethylpiperidinoxyl (TPO) and 4-OH-2,2,6,6-tetramethylpiperidinoxyl (4-OH-TPO) with the oxoammonium cation derived from TPO at various pHs using rapid-mixing stopped-flow and EPR spectrometry. From the pH dependence of the reaction rate constants we determined the pK 1 of the respective hydroxylamines to be 7.5 and 6.9, respectively. The reduction potentials of the hydroxylamines were determined by cyclic voltammetry, and from their dependence on pH, we obtained the same pK 1 values. The rate constant of the comproportionation reaction does not exceed 20 M -1 s -1 in the physiological pH range and, therefore, cannot greatly contribute toward recycling of the nitroxides in the tissue.
KW - Antioxidants
KW - Cyclic voltammetry
KW - Electron paramagnetic resonance
KW - Free radicals
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=11344268932&partnerID=8YFLogxK
U2 - 10.1016/j.freeradbiomed.2004.09.037
DO - 10.1016/j.freeradbiomed.2004.09.037
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 15629861
AN - SCOPUS:11344268932
SN - 0891-5849
VL - 38
SP - 317
EP - 324
JO - Free Radical Biology and Medicine
JF - Free Radical Biology and Medicine
IS - 3
ER -